
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
Brian M. Slomovitz, Karen H. Lu, Taren Johnston, Robert L. Coleman, Mark Munsell, Russell R. Broaddus, Cheryl Walker, Lois M. Ramondetta, Thomas W. Burke, David M. Gershenson, Judith WolfVolume:
116
Année:
2010
Langue:
english
Pages:
5
DOI:
10.1002/cncr.25515
Fichier:
PDF, 118 KB
english, 2010